Equity

Corporate Results

Glaxosmithkline Pharmaceuticals consolidated net profit rises 398.61% in the September 2019 quarter
(22-Oct-2019, 17:27 Hours IST)  
Net profit of Glaxosmithkline Pharmaceuticals rose 398.61% to Rs 502.75 crore in the quarter ended September 2019 as against Rs 100.83 crore during the previous quarter ended September 2018. Sales rose 8.05% to Rs 882.02 crore in the quarter ended September 2019 as against Rs 816.31 crore during the previous quarter ended September 2018.

ParticularsQuarter Ended
 Sep. 2019Sep. 2018% Var.
Sales882.02816.31 8
OPM %22.0020.22 -
PBDT208.97179.82 16
PBT186.27168.31 11
NP502.75100.83 399

Powered by Capital Market - Live News

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)